Please assess the completion status of the following clinical trial:

Trial Title: Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histological proven non-small cell or small cell lung cancer UICC stage I-III (in case of small cell lung cancer: limited stage)~* WHO performance status 0-2~* Less than 10 % weight loss the last 6 months~* In case of previous chemotherapy, concurrent chemo-radiotherapy can start after a minimum of 21 days after the last chemotherapy course~* No recent (\< 3 months) severe cardiac disease (arrhythmia, congestive heart failure, infarction)~* No active peptic oesophagitis~* Life expectancy more than 6 months~* Measurable cancer~* Willing and able to comply with the study prescriptions~* 18 years or older~* Not pregnant and willing to take adequate contraceptive measures during the study~* Have given written informed consent before patient registration~* No previous radiotherapy to the chest~Exclusion Criteria:~* Not non-small cell or small cell histology, e.g. mesothelioma, lymphoma~* Malignant pleural or pericardial effusion~* History of prior chest radiotherapy~* Recent (\< 3 months) myocardial infarction~* Uncontrolled infectious disease~* Distant metastases (stage IV)~* Patients with active peptic oesophagitis in the last year~* Less than 18 years old~* Pregnant or not willing to take adequate contraceptive measures during the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).